A Randomized, Double-Blind, Active-Controlled, Clinical Trial of the Safety, Efficacy, and Durability of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder

Phase: PHASE2 | Sponsor: U.S. Army Medical Research and Development Command | Compound: MDMA

Status

planned

Institution

U.S. Army Medical Research and Development Command

Start date

2026-10-01

End date

2028-10-01

Registry ID

NCT07704762

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.